Drug Metabolism Letters Impact Factor in Chemistry Journals

Drug Metabolism Letters in Chemistry Journals

Journal Country: United Arab Emirates
Journal Q tier: Q3
Publishing Firm: Bentham Science Publishers B.V.
History: 2007-2019, 2021
Journal Homepage: Not Available
Journal ISSN: 18740758, 18723128

Research Categories

Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Biochemistry (medical) (Q4); Clinical Biochemistry (Q4)

Impact Score: 1.17
h-Index: 31
SJR: 0.241
Ranking: 17215

About Drug Metabolism Letters

Drug Metabolism Letters is a journal covering the technologies/fields/categories related to Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Biochemistry (medical) (Q4); Clinical Biochemistry (Q4). It is published by Bentham Science Publishers B.V.. The overall rank of Drug Metabolism Letters is 17215.According to SCImago Journal Rank (SJR), this journal is ranked 0.241. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 31. The best quartile for this journal is Q3.The ISSN of Drug Metabolism Letters journal is 18740758, 18723128.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drug Metabolism Letters is cited by a total of 51 articles during the last 3 years (Preceding 2022).

Log in to add a review. Log in

No reviews yet. Be the first to review this journal.